Using our proprietary LLM-based pipelines, we:
✅ Replicated a published meta-analysis on antidepressants for IBS
✅ Identified 8 more relevant RCTs in addition to 20 in the original study
✅ Reproduced all meta-analytic computations
✅ Extended the analysis to include both odds ratios (OR) and risk ratios (RR)
✅ Completed the entire process within days of the original publication
📈 The result? Scientifically rigorous, reproducible, and extended findings – delivered faster than ever before.
This isn’t just automation. It’s intelligence applied to evidence – ensuring our clients stay ahead in clinical strategy, regulatory submissions, and HEOR.
If you’re a Pharma, CRO, or Med Affairs team navigating evidence generation – we’d love to show you what’s possible with AI.
🔗 Read the Letter to the Editor
Synthesa AI Validated at Scale: 100% Abstract Screening Sensitivity
16 February 2026
